Activation of non-canonical NF-κB pathway mediated by STP-A11, an oncoprotein of Herpesvirus saimiri

Virology

Volumn 359, Issue 1, 2007, Pages 37-45

  Cho, Il Rae ^a   Jeong, Sunam ^a   Jhun, Byung Hak ^a   An, Won G ^a   Lee, BokSoo ^b   Kwak, Youn Tae ^c   Lee, Sun Hwa ^d   Jung, Jae U ^d   Chung, Young Hwa ^a  

^a Pusan National University   (South Korea)

^b Wonkwang University   (South Korea)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Canonical NF B; Herpesvirus saimiri; IKK; NF B2; NIK; Non canonical NF B; p100 processing; p52 protein; STP A11

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; ONCOPROTEIN; PROTEIN P100; PROTEIN P52; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;

ARTICLE; BINDING SITE; CELL DEATH; CELL TRANSFORMATION; GENE TRANSLOCATION; HERPES VIRUS SAIMIRI; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAIN;

CELL DEATH; CELL LINE; CELL NUCLEUS; ENZYME INHIBITORS; HERPESVIRUS 2, SAIMIRIINE; HUMANS; LEUPEPTINS; NF-KAPPA B P52 SUBUNIT; ONCOGENE PROTEINS, VIRAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; RNA, SMALL INTERFERING;

SAIMIRI; SAIMIRIINE HERPESVIRUS 2;

EID: 33846847731     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.09.001     Document Type: Article

References (48)

1. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 6 3 (2004) 203-208
2. Atkinson P.G., Coope H.J., Rowe M., and Ley S.C. Latent membrane protein 1 of Epstein-Barr virus stimulates processing of NF-kappa B2 p100 to p52. J. Biol. Chem. 278 51 (2003) 51134-51142
3. Barkett M., and Gilmore T.D. Control of apoptosis by Rel/NF-kappaB transcription factors. Oncogene 18 49 (1999) 6910-6924
4. Biesinger B., Muller-Fleckenstein I., Simmer B., Lang G., Wittmann S., Platzer E., Desrosiers R.C., and Fleckenstein B. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc. Natl. Acad. Sci. U.S.A. 89 7 (1992) 3116-3119
5. Chung Y.H., Cho N.H., Garcia M.I., Lee S.H., Feng P., and Jung J.U. Activation of Stat3 transcription factor by Herpesvirus saimiri STP-A oncoprotein. J. Virol. 78 12 (2004) 6489-6497
6. Claudio E., Brown K., Park S., Wang H., and Siebenlist U. BAFF-induced NEMO-independent processing of NF-kappa B2 in maturing B cells. Nat. Immunol. 3 10 (2002) 958-965
7. Coope H.J., Atkinson P.G., Huhse B., Belich M., Janzen J., Holman M.J., Klaus G.G., Johnston L.H., and Ley S.C. CD40 regulates the processing of NF-kappaB2 p100 to p52. EMBO J. 21 20 (2002) 5375-5385
8. Damania B., Choi J.K., and Jung J.U. Signaling activities of gammaherpesvirus membrane proteins. J. Virol. 74 4 (2000) 1593-1601
9. Dejardin E., Droin N.M., Delhase M., Haas E., Cao Y., Makris C., Li Z.W., Karin M., Ware C.F., and Green D.R. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. Immunity 17 4 (2002) 525-535
10. Demicco E.G., Kavanagh K.T., Romieu-Mourez R., Wang X., Shin S.R., Landesman-Bollag E., Seldin D.C., and Sonenshein G.E. RelB/p52 NF-kappaB complexes rescue an early delay in mammary gland development in transgenic mice with targeted superrepressor IkappaB-alpha expression and promote carcinogenesis of the mammary gland. Mol. Cell. Biol. 25 22 (2005) 10136-10147
11. Dobrzanski P., Ryseck R.P., and Bravo R. Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity. EMBO J. 13 19 (1994) 4608-4616
12. Eliopoulos A.G., Caamano J.H., Flavell J., Reynolds G.M., Murray P.G., Poyet J.L., and Young L.S. Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling pathway. Oncogene 22 48 (2003) 7557-7569
13. Feinman R., Koury J., Thames M., Barlogie B., Epstein J., and Siegel D.S. Role of NF-kappaB in the rescue of multiple myeloma cells from glucocorticoid-induced apoptosis by bcl-2. Blood 93 9 (1999) 3044-3052
14. Franzoso G., Carlson L., Poljak L., Shores E.W., Epstein S., Leonardi A., Grinberg A., Tran T., Scharton-Kersten T., Anver M., Love P., Brown K., and Siebenlist U. Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187 2 (1998) 147-159
15. Futterer A., Mink K., Luz A., Kosco-Vilbois M.H., and Pfeffer K. The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity 9 1 (1998) 59-70
16. Ghosh S., and Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109 (2002) S81-S96 (Suppl.)
17. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
18. Griffin J.D. Leukemia stem cells and constitutive activation of NF-kappaB. Blood 98 8 (2001) 2291
19. Habelhah H., Takahashi S., Cho S.G., Kadoya T., Watanabe T., and Ronai Z. Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J. 23 2 (2004) 322-332
20. Hu Y., Baud V., Delhase M., Zhang P., Deerinck T., Ellisman M., Johnson R., and Karin M. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science 284 5412 (1999) 316-320
21. Jung J.U., and Desrosiers R.C. Identification and characterization of the herpesvirus saimiri oncoprotein STP-C488. J. Virol. 65 12 (1991) 6953-6960
22. Jung J.U., and Desrosiers R.C. Association of the viral oncoprotein STP-C488 with cellular ras. Mol. Cell. Biol. 15 12 (1995) 6506-6512
23. Jung J.U., Choi J.K., Ensser A., and Biesinger B. Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin. Cancer Biol. 9 3 (1999) 231-239
24. Kang H.S., Chin R.K., Wang Y., Yu P., Wang J., Newell K.A., and Fu Y.X. Signaling via LTbetaR on the lamina propria stromal cells of the gut is required for IgA production. Nat. Immunol. 3 6 (2002) 576-582
25. Karin M., and Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 18 (2000) 621-663
26. Karin M., and Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3 3 (2002) 221-227
27. Kaye K.M., Devergne O., Harada J.N., Izumi K.M., Yalamanchili R., Kieff E., and Mosialos G. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc. Natl. Acad. Sci. U.S.A. 93 20 (1996) 11085-11090
28. Kim K.E., Gu C., Thakur S., Vieira E., Lin J.C., and Rabson A.B. Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes. Oncogene 19 10 (2000) 1334-1345
29. Lee H., Choi J.K., Li M., Kaye K., Kieff E., and Jung J.U. Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP. J. Virol. 73 5 (1999) 3913-3919
30. Luftig M., Yasui T., Soni V., Kang M.S., Jacobson N., Cahir-McFarland E., Seed B., and Kieff E. Epstein-Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKK alpha-dependent noncanonical NF-kappaB activation. Proc. Natl. Acad. Sci. U.S.A. 101 1 (2004) 141-146
31. Medveczky P., Szomolanyi E., Desrosiers R.C., and Mulder C. Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J. Virol. 52 3 (1984) 938-944
32. Migliazza A., Lombardi L., Rocchi M., Trecca D., Chang C.C., Antonacci R., Fracchiolla N.S., Ciana P., Maiolo A.T., and Neri A. Heterogeneous chromosomal aberrations generate 3' truncations of the NFKB2/lyt-10 gene in lymphoid malignancies. Blood 84 11 (1994) 3850-3860
33. Mordmuller B., Krappmann D., Esen M., Wegener E., and Scheidereit C. Lymphotoxin and lipopolysaccharide induce NF-kappaB-p52 generation by a co-translational mechanism. EMBO Rep. 4 1 (2003) 82-87
34. Muller J.R., and Siebenlist U. Lymphotoxin beta receptor induces sequential activation of distinct NF-kappa B factors via separate signaling pathways. J. Biol. Chem. 278 14 (2003) 12006-12012
35. Neri A., Chang C.C., Lombardi L., Salina M., Corradini P., Maiolo A.T., Chaganti R.S., and Dalla-Favera R. B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-kappa B p50. Cell 67 6 (1991) 1075-1087
36. Neri A., Fracchiolla N.S., Roscetti E., Garatti S., Trecca D., Boletini A., Perletti L., Baldini L., Maiolo A.T., and Berti E. Molecular analysis of cutaneous B- and T-cell lymphomas. Blood 86 8 (1995) 3160-3172
37. Neri A., Fracchiolla N.S., Migliazza A., Trecca D., and Lombardi L. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies. Leuk. Lymphoma 23 1-2 (1996) 43-48
38. Palayoor S.T., Youmell M.Y., Calderwood S.K., Coleman C.N., and Price B.D. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18 51 (1999) 7389-7394
39. Senftleben U., Cao Y., Xiao G., Greten F.R., Krahn G., Bonizzi G., Chen Y., Hu Y., Fong A., Sun S.C., and Karin M. Activation by IKKalpha of a second, evolutionary conserved, NF-kappa B signaling pathway. Science 293 5534 (2001) 1495-1499
40. Shinkura R., Kitada K., Matsuda F., Tashiro K., Ikuta K., Suzuki M., Kogishi K., Serikawa T., and Honjo T. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 22 1 (1999) 74-77
41. Siebenlist U., Franzoso G., and Brown K. Structure, regulation and function of NF-kappa B. Annu. Rev. Cell Biol. 10 (1994) 405-455
42. Takeda K., Takeuchi O., Tsujimura T., Itami S., Adachi O., Kawai T., Sanjo H., Yoshikawa K., Terada N., and Akira S. Limb and skin abnormalities in mice lacking IKKalpha. Science 284 5412 (1999) 313-316
43. Wang Y., Cui H., Schroering A., Ding J.L., Lane W.S., McGill G., Fisher D.E., and Ding H.F. NF-kappa B2 p100 is a pro-apoptotic protein with anti-oncogenic function. Nat. Cell Biol. 4 11 (2002) 888-893
44. Xiao G., Cvijic M.E., Fong A., Harhaj E.W., Uhlik M.T., Waterfield M., and Sun S.C. Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. EMBO J. 20 23 (2001) 6805-6815
45. Xiao G., Harhaj E.W., and Sun S.C. NF-kappaB-inducing kinase regulates the processing of NF-kappaB2 p100. Mol. Cell. 7 2 (2001) 401-409
46. Yin M.J., Christerson L.B., Yamamoto Y., Kwak Y.T., Xu S., Mercurio F., Barbosa M., Cobb M.H., and Gaynor R.B. HTLV-I Tax protein binds to MEKK1 to stimulate IkappaB kinase activity and NF-kappaB activation. Cell 93 5 (1998) 875-884
47. Yoshida H., Kato N., Shiratori Y., Otsuka M., Maeda S., Kato J., and Omata M. Hepatitis C virus core protein activates nuclear factor kappa B-dependent signaling through tumor necrosis factor receptor-associated factor. J. Biol. Chem. 276 19 (2001) 16399-16405
48. Zhang G., and Ghosh S. Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity. J. Clin. Invest. 107 1 (2001) 13-19